A. Bernat

2.4k total citations
68 papers, 2.0k citations indexed

About

A. Bernat is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, A. Bernat has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 25 papers in Cardiology and Cardiovascular Medicine and 19 papers in Surgery. Recurrent topics in A. Bernat's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (15 papers). A. Bernat is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (15 papers). A. Bernat collaborates with scholars based in France, Italy and Brazil. A. Bernat's co-authors include Jean‐Marc Herbert, Maurice Petitou, J.P. Maffrand, Pierre Savi, J. M. Herbert, J C Lormeau, Jean-P. Hérault, Philippe Duchaussoy, Pierre‐Alexandre Driguez and Jean‐Claude Lormeau and has published in prestigious journals such as Nature, Blood and Circulation Research.

In The Last Decade

A. Bernat

67 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
A. Bernat	874	704	574	568	334	68	2.0k
Lucia Stefanini	340 0.4×	747 1.1×	100 0.2×	192 0.3×	379 1.1×	47	1.5k
Jean‐Marc Herbert	426 0.5×	127 0.2×	182 0.3×	250 0.4×	403 1.2×	37	1.2k
Jiro Seki	232 0.3×	256 0.4×	36 0.1×	231 0.4×	351 1.1×	66	1.2k
John C. Kermode	120 0.1×	250 0.4×	77 0.1×	250 0.4×	432 1.3×	40	1.2k
DW Perry	280 0.3×	591 0.8×	51 0.1×	141 0.2×	162 0.5×	16	1.0k
Kyungho Kim	168 0.2×	419 0.6×	59 0.1×	122 0.2×	492 1.5×	46	1.5k
White Jg	117 0.1×	358 0.5×	55 0.1×	103 0.2×	225 0.7×	56	970
Repin Vs	189 0.2×	194 0.3×	18 0.0×	460 0.8×	511 1.5×	136	1.5k
Beverley Koller	348 0.4×	147 0.2×	55 0.1×	102 0.2×	322 1.0×	9	1.3k

Countries citing papers authored by A. Bernat

Since Specialization

Citations

This map shows the geographic impact of A. Bernat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bernat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bernat more than expected).

Fields of papers citing papers by A. Bernat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bernat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bernat. The network helps show where A. Bernat may publish in the future.

Co-authorship network of co-authors of A. Bernat

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bernat. A scholar is included among the top collaborators of A. Bernat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bernat. A. Bernat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schaeffer, Paul, A. Bernat, M. Arnone, et al.. (2005). Effect of SR58611A, a potent beta-3 adrenoceptor agonist, on cutaneous wound healing in diabetic and obese mice. European Journal of Pharmacology. 529(1-3). 172–178. 10 indexed citations

Bernat, A., et al.. (1999). Interspecies Comparison of the Antiplatelet, Antithrombotic, and Hemorrhagic Effects of SR 121566A, a Novel Nonpeptide GP IIb/IIIa Antagonist. Journal of Cardiovascular Pharmacology. 33(6). 897–904. 8 indexed citations

Petitou, Maurice, Jean-Pascal Hérault, A. Bernat, et al.. (1999). Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature. 398(6726). 417–422. 266 indexed citations

Hoffmann, Peter, A. Bernat, Pierre Savi, & J. M. Herbert. (1998). Prevention of Thrombosis and Enhancement of Thrombolysis in Rabbits by SR 121787, a Glycoprotein II/III Antagonist. Journal of Pharmacology and Experimental Therapeutics. 286(2). 670–675. 5 indexed citations

Schaeffer, Paul, et al.. (1998). SR142948A is a Potent Antagonist of the Cardiovascular Effects of Neurotensin. Journal of Cardiovascular Pharmacology. 31(4). 545–550. 16 indexed citations

Hoffmann, Peter, et al.. (1997). THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 DOES NOT RELEASE LIPASE ACTIVITY INTO THE PLASMA. Thrombosis Research. 86(4). 325–332. 3 indexed citations

Schaeffer, Paul, et al.. (1997). Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the rat. European Journal of Pharmacology. 323(2-3). 215–221. 13 indexed citations

Hoffmann, Peter, A. Bernat, Pierre Savi, & J. M. Herbert. (1997). Antiplatelet and Antithrombotic Efficacy of SR 121787, a Nonpeptide Orally Active GP IIb/IIIa Antagonist, in Rabbits: Comparison with Clopidogrel and Aspirin. Journal of Cardiovascular Pharmacology. 30(3). 360–366. 17 indexed citations

Herbert, Jean‐Marc, et al.. (1996). Hypoxia primes endotoxin-induced tissue factor expression in human monocytes and endothelial cells by a PAF-dependent mechanism. Journal of Cellular Physiology. 169(2). 290–299. 19 indexed citations

10.

Bernat, A. & Jean‐Marc Herbert. (1996). Protamine Sulphate Inhibits Pentasaccharide (SR 80027)-Induced Bleeding without Affecting Its Antithrombotic and Anti-Factor Xa Activity in the Rat. Pathophysiology of Haemostasis and Thrombosis. 26(4). 195–202. 7 indexed citations

11.

Herbert, Jean‐Marc, A. Bernat, & Pierre Savi. (1995). Hypercholesterolemia Does Not Affect the Antiplatelet Activity of Clopidogrel. Platelets. 6(6). 412–413. 2 indexed citations

12.

Bernat, A., et al.. (1994). Aurin tricarboxylic acid inhibits experimental venous thrombosis. Thrombosis Research. 74(6). 617–627. 7 indexed citations

13.

Savi, Pierre, et al.. (1994). Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells. Thrombosis Research. 73(2). 117–124. 24 indexed citations

14.

Bernat, A., et al.. (1994). Low Doses of Endotoxin Potentiate Venous Thrombosis in the Rabbit. Pathophysiology of Haemostasis and Thrombosis. 24(4). 209–218. 6 indexed citations

15.

Bernat, A., et al.. (1994). Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: Importance of PAF. Thrombosis Research. 75(1). 91–97. 13 indexed citations

16.

Bernat, A., Jean‐Pierre Maffrand, & Jean‐Marc Herbert. (1993). Circannual Variations of the Bleeding Time in the Rat. Chronobiology International. 10(5). 360–363. 1 indexed citations

17.

Bernat, A., et al.. (1993). Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat. Thrombosis Research. 71(6). 433–441. 37 indexed citations

18.

Herbert, Jean Marc, et al.. (1992). Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen. European Journal of Pharmacology. 216(2). 175–181. 7 indexed citations

19.

Courtney, Michael, G. Loison, Yves Lemoine, et al.. (1989). Production and Evaluation of Recombinant Hirudin. Seminars in Thrombosis and Hemostasis. 15(3). 288–292. 15 indexed citations

20.

Bernat, A., et al.. (1989). Pharmacology of Ticlopidine: A Review. Seminars in Thrombosis and Hemostasis. 15(2). 159–166. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact